APREPITANT 40 MG CAPSULE

aprepitant
$40.6600per EA

Strength

40 mg/1

Manufacturer

Sandoz Inc.

NDC

00781232151

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

APREPITANT

Approval Type

Generic (ANDA)

FDA Application

ANDA090999

On Market Since

12/27/2016

Pharmacological Classes

Cytochrome P450 2C9 Inducers
Cytochrome P450 3A4 Inducers
Cytochrome P450 3A4 Inhibitors
Neurokinin 1 Antagonists
Substance P/Neurokinin-1 Receptor Antagonist

Price History

1W

0.0%

1M

-4.2%

3M

-13.5%

6M

-12.2%

1Y

-9.8%

3Y

-22.1%

5Y

-44.1%

All

-46.4%

Generic Alternatives

1 alternative • Same active ingredient